Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Steriflex No.31 glucose 20% infusion 500ml bags
0902021G0BFAKBB
|
Steriflex glucose | Glucose | Nutrition and Blood | No data available |
|
Steriflex No.33 glucose 40% infusion 500ml bags
0902021G0BFAIBE
|
Steriflex glucose | Glucose | Nutrition and Blood | No data available |
|
Steriflex No.34 glucose 50% infusion 500ml bags
0902021G0BFAJAY
|
Steriflex glucose | Glucose | Nutrition and Blood | No data available |
|
Steriflex No.6 glucose 5% infusion 1litre bags
0902021G0BFAABD
|
Steriflex glucose | Glucose | Nutrition and Blood | No data available |
|
Steriflex No.6 glucose 5% infusion 500ml bags
0902021G0BFABBC
|
Steriflex glucose | Glucose | Nutrition and Blood | No data available |
|
Steriflex No.6 glucose 5% infusion 50ml bags
0902021G0BFAGBG
|
Steriflex glucose | Glucose | Nutrition and Blood | No data available |
|
Steriflex No.6 minipack glucose 5% infusion 100ml bags
0902021G0BFAEA3
|
Steriflex glucose | Glucose | Nutrition and Blood | No data available |
|
Steriflex No.6 minipack glucose 5% infusion 250ml bags
0902021G0BFAFAU
|
Steriflex glucose | Glucose | Nutrition and Blood | No data available |
|
Steriflex No.7 glucose 10% infusion 1litre bags
0902021G0BFACA8
|
Steriflex glucose | Glucose | Nutrition and Blood | No data available |
|
Steriflex No.7 glucose 10% infusion 500ml bags
0902021G0BFAHA9
|
Steriflex glucose | Glucose | Nutrition and Blood | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.